Hans Peter Guler - Net Worth and Insider Trading
Hans Peter Guler Net Worth
The estimated net worth of Hans Peter Guler is at least $9 Million dollars as of 2024-11-13. Hans Peter Guler is the VP Clinical Programs of Regeneron Pharmaceuticals Inc and owns about 10,530 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $9 Million. Details can be seen in Hans Peter Guler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hans Peter Guler has not made any transactions after 2004-10-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hans Peter Guler
Hans Peter Guler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hans Peter Guler owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Hans Peter Guler’s form 4 insider trades.
Insider Ownership Summary of Hans Peter Guler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2004-10-08 | VP & Clinical Sciences |
Hans Peter Guler Latest Holdings Summary
Hans Peter Guler currently owns a total of 1 stock. Hans Peter Guler owns 10,530 shares of Regeneron Pharmaceuticals Inc (REGN) as of October 8, 2004, with a value of $9 Million.
Latest Holdings of Hans Peter Guler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2004-10-08 | 10,530 | 821.00 | 8,645,130 |
Holding Weightings of Hans Peter Guler
Hans Peter Guler Form 4 Trading Tracker
According to the SEC Form 4 filings, Hans Peter Guler has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 31,000 shares on October 8, 2004, which brought Hans Peter Guler around $246,450.
Insider Trading History of Hans Peter Guler
- 1
Hans Peter Guler Trading Performance
Hans Peter Guler Ownership Network
Ownership Network List of Hans Peter Guler
Ownership Network Relation of Hans Peter Guler
Hans Peter Guler Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Hans Peter Guler is the VP & Clinical Sciences of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Hans Peter Guler made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Hans Peter Guler Mailing Address
Above is the net worth, insider trading, and ownership report for Hans Peter Guler. Currently GuruFocus does not have mailing address information for Hans Peter Guler.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
